Stannous chloride is used as a source of tin in radiopharmaceutical kits. Tin reduces technetium-99m, the active radiological agent, allowing it to form a complex with phosphate-containing moeities . These... These complexes localize primarily in bone (40-50%) and infracted myocardium (0.01-0.02%/g of tissue) allowing for imaging of areas of altered osteogenesis or necrotic heart tissue.
- Mechanism
- Curator reviewed
Stannous chloride acts as a reducing agent for technetium-99m allowing formation of a Tc99m-Sn-pyrophosphate complex in combination sodium pyrophosphate. See DB09165 for information on the active agent.
- Primary indication
- Stannous chloride is a component of technetium-99m agents indicated for imaging of the skeleton for areas of altered osteogenesis or in the detection of infarcted heart tissue.Curator reviewed · 1 structured indication
- Formula / weight
- Cl2Sn · 189.62 g/mol (avg)
- First approval
- Canada, 1998 · United States, 1991
- Also known as
- Tin dichloride
- Brand names
Resolves to
AXZWODMDQAVCJE-UHFFFAOYSA-LSMILES[Cl-].[Cl-].[Sn++]What you can answer from here — as of August 30, 2026
Which drugs share a target with Stannous chloride, and which of those have an active Phase 3 trial?
Create a free account or log in to explore the full data card.
Create Account